Tag Archives: customized pharmaceutical in Colorado

Voluntarily removed from the human market by the FDA in 2007 and no longer available in tablet form, pergolide mesylate (proprietary name Permax) remains a frequently requested active ingredient in compounds prescribed by horse veterinarians treating pituitary pars intermedia dysfunction … Continue reading →